drugset / Trial / NCT00053924

Perifosine in Treating Patients With Advanced Pancreatic Cancer

NCT00053924

Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of perifosine in treating patients who have locally advanced or metastatic pancreatic cancer.

Timeline

Start
2003-05
Primary completion
2006-05
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Perifosine Small molecule Oral